Transcription factor Sp1 dysregulation in Alzheimer's disease.
about
TcoF-DB: dragon database for human transcription co-factors and transcription factor interacting proteinsRedox Imbalance and Viral Infections in Neurodegenerative DiseasesGene environment interaction in periphery and brain converge to modulate behavioral outcomes: Insights from the SP1 transient early in life interference rat modelEpigenetic Changes in Neurodegenerative DiseasesMolecular mechanism of monoamine oxidase A gene regulation under inflammation and ischemia-like conditions: key roles of the transcription factors GATA2, Sp1 and TBPShort-term treatment with tolfenamic acid improves cognitive functions in Alzheimer's disease miceAPOE*E2 allele delays age of onset in PSEN1 E280A Alzheimer's disease.Genetic diversity and striatal gene networks: focus on the heterogeneous stock-collaborative cross (HS-CC) mouse.Transcription of the transforming growth factor beta activating integrin beta8 subunit is regulated by SP3, AP-1, and the p38 pathway.Integrated multi-cohort transcriptional meta-analysis of neurodegenerative diseases.Enhanced taupathy and AD-like pathology in aged primate brains decades after infantile exposure to lead (Pb).Transcription factors Sp1 and Sp4 regulate TRPV1 gene expression in rat sensory neurons.Systematic analysis of transcription-level effects of neurodegenerative diseases on human brain metabolism by a newly reconstructed brain-specific metabolic networkTolfenamic acid reduces tau and CDK5 levels: implications for dementia and tauopathies.Genomics in neurological disorders.CR6-interacting factor 1 is a key regulator in Aβ-induced mitochondrial disruption and pathogenesis of Alzheimer's disease.The renaissance of Ca2+-binding proteins in the nervous system: secretagogin takes center stage.BACE2 expression increases in human neurodegenerative disease.Finding novel distinctions between the sAPPα-mediated anabolic biochemical pathways in Autism Spectrum Disorder and Fragile X Syndrome plasma and brain tissuePathways to neurodegeneration: mechanistic insights from GWAS in Alzheimer's disease, Parkinson's disease, and related disordersmiRNAs: Key Players in Neurodegenerative Disorders and EpilepsyWhole Genome Expression Analysis in a Mouse Model of Tauopathy Identifies MECP2 as a Possible Regulator of Tau Pathology.The beneficial role of vitamin D in Alzheimer's disease.Role of thiamine in Alzheimer's disease.Inflammation in Alzheimer disease-a brief review of the basic science and clinical literature.Identification of active transcription factor and miRNA regulatory pathways in Alzheimer's disease.Presenilin 2 deficiency facilitates Aβ-induced neuroinflammation and injury by upregulating P2X7 expression.Regulation of LRRK2 promoter activity and gene expression by Sp1.The PKR activator PACT is induced by Aβ: involvement in Alzheimer's disease.Bioinformatics identification of modules of transcription factor binding sites in Alzheimer's disease-related genes by in silico promoter analysis and microarrays.Transcription factor Sp1 inhibition, memory, and cytokines in a mouse model of Alzheimer's disease.Targeted Downregulation of dMyc Suppresses Pathogenesis of Human Neuronal Tauopathies in Drosophila by Limiting Heterochromatin Relaxation and Tau Hyperphosphorylation.DNA methylation of Alzheimer disease and tauopathy-related genes in postmortem brain.Heat Shock Cognate 70 Inhibitor, VER-155008, Reduces Memory Deficits and Axonal Degeneration in a Mouse Model of Alzheimer's Disease.Screening of Potential Genes and Transcription Factors of Postoperative Cognitive Dysfunction via Bioinformatics Methods.Mithramycin A Alleviates Cognitive Deficits and Reduces Neuropathology in a Transgenic Mouse Model of Alzheimer's Disease.
P2860
Q24607892-14C48A51-0BE4-40D9-AC08-274B3711E95BQ26750630-8A1567CA-E61E-4AA5-836E-405761194282Q28066795-2C144C14-98BB-415F-AEDA-07DB5C8A047EQ28075559-4648B5FE-513E-4DC3-8268-348155379E0AQ28259446-7E70E957-E90F-449A-BBD9-E18F32BD2D37Q30541295-1DEF654B-EEC9-4005-BD63-C2BAA5DEEC6AQ33629402-6C7059BE-674C-4595-8EA6-DDA506EFD4A7Q33722841-7FCD08EF-80DE-4F48-8D32-EF98A40F0350Q34042666-33794C0C-00E1-49BA-9F7A-74B1F8CE19EBQ34202948-0B53796F-91E8-4260-8968-4728777166E6Q34655631-0750699B-38D9-4135-BB64-9D26A5A046C6Q35063692-2B7C62CF-1AFF-44B3-A15E-4EF5FC7A4EB6Q35213003-F8612757-A77D-4F29-96E2-BEB744C0933EQ35264520-8BB4EF15-F028-4A72-8C41-DB1455E36879Q35543494-91EEB0BF-3538-43E2-BE2B-3145826822ACQ35579286-1E1E3AD0-9209-4D4A-9AEC-5D04900CAE13Q35613257-BC0AC0B1-93EB-45CD-B52B-4B871E64CF5BQ35917682-5B01E6DD-5034-4485-B808-28004B26F1C8Q36925690-07921A82-30B9-4829-943E-039CFB2A5845Q37199221-EAEC277E-85E8-40ED-A30C-87B7CFC26EDAQ37535111-6D9B2ABF-BF78-482B-BBD7-27FDCC86353DQ37707241-1F0DDC91-033C-4AF3-B44F-143110E5629BQ37971804-91141336-F798-4066-894C-F43F16AD9998Q37973263-5387A491-F49A-4D2D-A7DE-4241FD0E14CEQ37982377-8E66B377-5E1E-49A8-A304-1501B72AE398Q38132722-1CAC5D1E-1114-4122-9A2F-08612BB5BF1BQ38719556-88BF99FD-2C0C-4056-B549-BE0A7B946F04Q39322027-04E4E088-12A4-4176-93E2-FEA56639E4A4Q39500707-B832208E-551D-46DB-A1BC-C0C987F232F7Q42728923-465F1F04-09CF-4C48-87EC-7520EEF5F907Q43106647-7C1A72E8-AEB9-4361-AA05-44A8971C02D0Q46576148-297DFAF3-78FF-41C8-BA48-938E3D8706AEQ48521070-9FB7B214-CCB7-4AC0-969A-24D7239262C3Q49544213-C4CFC15A-4A67-4A19-8338-47523B7A0B54Q49642709-3BAED446-EB38-40C6-AE24-40716196ED60Q50520724-2197B35B-D906-4AA8-B000-60E7BC74D6C4
P2860
Transcription factor Sp1 dysregulation in Alzheimer's disease.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Transcription factor Sp1 dysregulation in Alzheimer's disease.
@en
Transcription factor Sp1 dysregulation in Alzheimer's disease.
@nl
type
label
Transcription factor Sp1 dysregulation in Alzheimer's disease.
@en
Transcription factor Sp1 dysregulation in Alzheimer's disease.
@nl
prefLabel
Transcription factor Sp1 dysregulation in Alzheimer's disease.
@en
Transcription factor Sp1 dysregulation in Alzheimer's disease.
@nl
P2093
P356
P1476
Transcription factor Sp1 dysregulation in Alzheimer's disease.
@en
P2093
Bruce A Citron
John S Dennis
Ross S Zeitlin
P304
P356
10.1002/JNR.21695
P577
2008-08-01T00:00:00Z